Back to December 2009: Updates from the 2009 San Antonio Breast Cancer Symposium
Most encouraging news from the conference?
- Question from rebecca: What was the most encouraging news you heard at the San Antonio conference this year?
- Answer —Kathy Miller, M.D. : I think it was the Phase III trial comparing denosumab to Zometa in women with metastatic disease involving the bones. This is an important and common problem for women with metastatic disease. Denosumab was more effective and had fewer side effects, and I think will be a big advance for our patients.